DA
Insider
David Altshuler
EVP, Chief Scientific OfficerDavid Altshuler (EVP, Chief Scientific Officer) filed 6 Form 4 reports in the past 24 months (0 purchases, 6 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $1.6M of VRTX (3,231 sh × $510.00, as filed), executed Mar 13 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.4M
shares × price, as filed
Last traded
Mar 13 2025
Filed Mar 17 2025
Median ADV $756.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 24 months
Most traded names
VRTX
Vertex Pharmaceuticals Incorporated
VRTX · 0 buys · 6 sells
6 filings
Recent filings
VRTXSALE
Vertex Pharmaceuticals Incorporated
View filing →
$1.6M3,231 sh × $510.00
Exec Mar 13 2025
Filed Mar 17 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $1.6M
3,231 sh × $500.00
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $1.6M
3,231 sh × $490.00
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $611K
1,272 sh × $480.00
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $408K
848 sh × $480.95
Exec Feb 25 2025
Filed Feb 26 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $533K
1,111 sh × $480.00
Exec Feb 20 2025
Filed Feb 24 2025 · 5:30 PM ET